echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Bihuan Pharmaceutical's Doxycycline Hydrochloride Tablets Passed the Consistency Evaluation of Generic Drugs

    Bihuan Pharmaceutical's Doxycycline Hydrochloride Tablets Passed the Consistency Evaluation of Generic Drugs

    • Last Update: 2022-05-21
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On April 14, Bihuan Pharmaceutical announced that the company had recently received the "Approval Notice for Supplementary Application for Doxycycline Hydrochloride Tablets" approved and issued by the State Food and Drug Administration.


    Doxycycline hydrochloride belongs to the tetracycline class of antibiotics and is a broad-spectrum bacteriostatic agent


    The PDB drug comprehensive database shows that the sales of terminal doxycycline hydrochloride tablet samples in Chinese public medical institutions will be 2.


    After querying the Yaozhi.


    Up to now, the company's R&D investment in the consistency evaluation of doxycycline hydrochloride tablets is approximately RMB 10,564,700 (unaudited)


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.